−81.89 MUSD
7.50 MUSD
About Mesoblast Limited
Sector
Industry
CEO
Silviu Itescu
Website
Headquarters
Melbourne
Employees (FY)
83
Founded
2004
ISIN
US5907174016
FIGI
BBG000QD6LZ1
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
